In case you missed it, Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former domestic policy adviser under the previous administration, asked Members of Congress a critical question in a new op-ed published in Townhall: Congress wants
A simple fact is often lost in the din of the current drug pricing debate going on in Washington D.C. and around the country: Drug companies retain the great majority of the prescription drug dollar. What is the prescription drug
The evidence is clear: prescription drug rebates negotiated by pharmacy benefit companies with drug companies are not correlated with drug list prices, which are set solely by drug companies. A recent analysis using Centers for Medicare and Medicaid Services (CMS)
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) announced the Virtual PBM Policy Forum 2021, featuring health care, pharmacy benefit managers (PBMs), and pharmaceutical manufacturer industry thought leaders and executives discussing how the public and private sectors are tackling
According to a new analysis, there are now 70 PBMs operating in a diverse and competitive marketplace.
Adam Kautzner, Pharm.D. President, Express Scripts Adam Kautzner is President of Express Scripts, one of the nation’s leading pharmacy benefit management (PBM) companies that serves more than 112 million Americans. Express Scripts is part of Evernorth, which connects and coordinates
With so many important issues being debated today, there are few topics that health care, legal, and economic experts agree on. But the fact that drug companies are the root cause of high prescription drug prices is one common denominator
©2024 PCMA. All Rights Reserved.
